SEC Comment Letter 0000000000-24-013575 to WORK Medical Technology Group LTD (WOK)

WORK Medical Technology Group LTD
Date: Dec. 9, 2024 · CIK: 0001929783 · Accession: 0000000000-24-013575

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

December 9, 2024

Author

Nicholas O'Leary

Form

UPLOAD

Company

WORK Medical Technology Group LTD

Letter

December 9, 2024 Shuang Wu Chief Executive Officer WORK Medical Technology Group LTD Floor 23, No. 2 Tonghuinan Road Xiaoshan District, Hangzhou City, Zhejiang Province The People’s Republic of China Re:WORK Medical Technology Group LTD Draft Registration Statement on Form F-1 Submitted December 2, 2024 CIK No. 0001929783 Dear Shuang Wu: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement no later than 48 hours prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Nicholas O'Leary at 202-551-4451 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc:Ying Li, Esq.

Show Raw Text

December 9, 2024
Shuang Wu
Chief Executive Officer
WORK Medical Technology Group LTD
Floor 23, No. 2 Tonghuinan Road
Xiaoshan District, Hangzhou City, Zhejiang Province
The People’s Republic of China
Re:WORK Medical Technology Group LTD
Draft Registration Statement on Form F-1
Submitted December 2, 2024
CIK No. 0001929783
Dear Shuang Wu:
            This is to advise you that we do not intend to review your registration statement.
            We request that you publicly file your registration statement no later than 48 hours
prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding
requests for acceleration. We remind you that the company and its management are
responsible for the accuracy and adequacy of their disclosures, notwithstanding any review,
comments, action or absence of action by the staff.
            Please contact Nicholas O'Leary at 202-551-4451 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:Ying Li, Esq.

SecProbe.io